Mark Willis

2.4k total citations · 1 hit paper
54 papers, 869 citations indexed

About

Mark Willis is a scholar working on Pathology and Forensic Medicine, Neurology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mark Willis has authored 54 papers receiving a total of 869 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pathology and Forensic Medicine, 8 papers in Neurology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mark Willis's work include Multiple Sclerosis Research Studies (21 papers), Peripheral Neuropathies and Disorders (6 papers) and 3D Surveying and Cultural Heritage (5 papers). Mark Willis is often cited by papers focused on Multiple Sclerosis Research Studies (21 papers), Peripheral Neuropathies and Disorders (6 papers) and 3D Surveying and Cultural Heritage (5 papers). Mark Willis collaborates with scholars based in United Kingdom, United States and Australia. Mark Willis's co-authors include Neil P. Robertson, Emma Tallantyre, Fady Joseph, Trevor Pickersgill, Katharine Harding, Mark Wardle, Valentina Tomassini, Owain Williams, James Hrastelj and William R. Mac Kenzie and has published in prestigious journals such as New England Journal of Medicine, PLoS ONE and Hepatology.

In The Last Decade

Mark Willis

52 papers receiving 844 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Clinical Outcomes of Escalation vs Early Intensive Disease-Modifying Therapy in Patients With Multiple Sclerosis

2019 227 citations Katharine Harding, Owain Williams et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark Willis United Kingdom	15	433	177	140	119	112	54	869
Ilaria Muller Italy	18	443 1.0×	183 1.0×	64 0.5×	52 0.4×	69 0.6×	58	1.2k
Lisa K. Peterson United States	16	163 0.4×	68 0.4×	167 1.2×	97 0.8×	142 1.3×	53	1.1k
Gorana Capkun Switzerland	12	267 0.6×	67 0.4×	75 0.5×	73 0.6×	123 1.1×	24	519
Sarah L. Stein United States	17	172 0.4×	29 0.2×	51 0.4×	103 0.9×	115 1.0×	73	1.0k
Gabriela Medina Mexico	24	257 0.6×	124 0.7×	74 0.5×	757 6.4×	165 1.5×	83	1.7k
James Anderson United Kingdom	19	101 0.2×	96 0.5×	245 1.8×	174 1.5×	285 2.5×	69	1.5k
Joanna Gibson United States	19	168 0.4×	61 0.3×	260 1.9×	42 0.4×	138 1.2×	52	1.0k
Susan Coventry United States	18	127 0.3×	47 0.3×	36 0.3×	52 0.4×	46 0.4×	40	943
Fumihiro Ogawa Japan	19	53 0.1×	91 0.5×	220 1.6×	65 0.5×	135 1.2×	74	1.0k

Countries citing papers authored by Mark Willis

Since Specialization

Citations

This map shows the geographic impact of Mark Willis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Willis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Willis more than expected).

Fields of papers citing papers by Mark Willis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Willis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Willis. The network helps show where Mark Willis may publish in the future.

Co-authorship network of co-authors of Mark Willis

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Willis. A scholar is included among the top collaborators of Mark Willis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Willis. Mark Willis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Harrison‐Buck, Eleanor, et al.. (2024). Late Archaic large-scale fisheries in the wetlands of the pre-Columbian Maya Lowlands. Science Advances. 10(47). eadq1444–eadq1444. 1 indexed citations

Messina, Silvia, Bo Chen, Αθανάσιος Παπαθανασίου, et al.. (2024). Cerebral cortical encephalitis in adults with myelin oligodendrocyte glycoprotein antibody‐associated disease: A national case series. European Journal of Neurology. 32(1). e16550–e16550. 1 indexed citations

Carr, Aisling, Frederick W. Vonberg, Kate Young, et al.. (2024). Neurological complications of immune checkpoint inhibitors: a practical guide. Practical Neurology. 25(2). 116–126. 7 indexed citations

Wesley, Daryl, et al.. (2023). A changing perspective: the impact of landscape evolution on rock art viewsheds. Archaeological and Anthropological Sciences. 16(1).

Moffat, Ian, et al.. (2023). Reconstructing archaeological palaeolandscapes using geophysical and geomatic survey techniques: An example from Red Lily Lagoon, Arnhem Land, Australia. PLoS ONE. 18(5). e0283006–e0283006. 2 indexed citations

Harding, Katharine, Gillian Ingram, Emma Tallantyre, et al.. (2022). Contemporary study of multiple sclerosis disability in South East Wales. Journal of Neurology Neurosurgery & Psychiatry. 94(4). 272–279. 4 indexed citations

Willis, Mark, et al.. (2022). 120 UK multiple sclerosis registries project: disease modifying treatment durability. Journal of Neurology Neurosurgery & Psychiatry. 93(9). e2.73–e2.73. 1 indexed citations

Willis, Mark, et al.. (2019). More than pretty pictures: A decade of aerial imagery and photogrammetry in northern Ecuador. 1 indexed citations

Allen, Christopher, Mark Willis, Marisa McGinley, et al.. (2019). Clinical observation during alemtuzumab administration. Multiple Sclerosis and Related Disorders. 37. 101412–101412. 1 indexed citations

10.

Willis, Mark & Neil P. Robertson. (2019). Neurotoxicity of novel cancer immunotherapies. Journal of Neurology. 266(8). 2087–2089. 3 indexed citations

11.

Muller, Ilaria, Mark Willis, Samantha Loveless, et al.. (2018). Longitudinal Characterization of Autoantibodies to the Thyrotropin Receptor (TRAb) During Alemtuzumab Therapy: Evidence that TRAb May Precede Thyroid Dysfunction by Many Years. Thyroid. 28(12). 1682–1693. 22 indexed citations

12.

Harding, Katharine, Valerie Anderson, Owain Williams, et al.. (2018). A contemporary study of mortality in the multiple sclerosis population of south east Wales. Multiple Sclerosis and Related Disorders. 25. 186–191. 9 indexed citations

13.

Tallantyre, Emma, Fady Joseph, Valentina Tomassini, et al.. (2018). How common is truly benign MS in a UK population?. Journal of Neurology Neurosurgery & Psychiatry. 90(5). 522–528. 20 indexed citations

14.

Willis, Mark, et al.. (2017). Online patient information on Vagus Nerve Stimulation: How reliable is it for facilitating shared decision making?. Seizure. 50. 125–129. 11 indexed citations

15.

Willis, Mark & Neil P. Robertson. (2016). Alemtuzumab for Multiple Sclerosis. Current Neurology and Neuroscience Reports. 16(9). 84–84. 42 indexed citations

16.

Clement, Mathew, James A. Pearson, Stéphanie Gras, et al.. (2016). Targeted suppression of autoreactive CD8+ T-cell activation using blocking anti-CD8 antibodies. Scientific Reports. 6(1). 35332–35332. 20 indexed citations

17.

Darling, J. Andrew, et al.. (2015). Groundtruthing from the Air: Reconstructing Tribal Agricultural and Landscape Systems in the Lower Chama Valley, New Mexico Using Low Elevation UAV Technology.. 1 indexed citations

18.

Willis, Mark & Neil Robertson. (2015). Alemtuzumab for the treatment of multiple sclerosis. Therapeutics and Clinical Risk Management. 11. 525–525. 15 indexed citations

19.

Hirst, Claire, et al.. (2015). Acute myeloid leucaemia presenting as a rapidly progressive polyradiculoneuropathy. BMJ Case Reports. 2015. bcr2015209556–bcr2015209556. 1 indexed citations

20.

Willis, Mark & Neil P. Robertson. (2014). Drug safety evaluation of alemtuzumab for multiple sclerosis. Expert Opinion on Drug Safety. 13(8). 1115–1124. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact